Neutropenia is associated with improved survival in colorectal cancer patients

What is it about?

Chemotherapy-induced neutropenia is a common adverse event in cancer patients undergoing chemotherapy. We have shown that Chemotherapy-induced neutropenia in colorectal cancer patients, particularly in metastatic colorectal cancer patients, had a potential benefit for survival.

Featured Image

Why is it important?

Our findings show that Chemotherapy-induced neutropenia, which caused by a particular dosage of a chemotherapeutic agent, may also be a surrogate marker to assess whether patients receive an effective or adequate active dose. Actually, the recommended dosage of chemotherapy was obtained from a small number of patients, do not take into account the interindividual variability of drug metabolism, so it may not suitable for everybody.

Perspectives